NORDICPRO-C6
Live / Registered — Registered (as of 09 Sept 2025)
What this means for you
Registered since 09 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79380032
- Registration number
- 7933249
- Mark type
- Stylized text
- Filed
- 19 Jul 2023
- Published for opposition
- 22 Jul 2025
- Registered
- 09 Sept 2025
- Attorney of record
- Andrew M. Smith
Goods and services
- Class 005 — Pharmaceuticals: diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use
- Class 042 — Scientific and technological services: custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing
Owner
Prosecution history
- 24 Mar 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Mar 2026 — FINAL DISPOSITION PROCESSED
- 09 Dec 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jul 2025 — PUBLISHED FOR OPPOSITION
- 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2025 — EXAMINER'S AMENDMENT ENTERED
- 17 Jun 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Jun 2025 — EXAMINERS AMENDMENT E-MAILED
- 17 Jun 2025 — EXAMINERS AMENDMENT -WRITTEN
- 22 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 04 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB